Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 71% · prior close shown (market closed)
Twist Bioscience Corp shows stable business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +23% YoY in Q4 FY2026.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 0d ago
Reported figures for Twist Bioscience Corp — research only, not investment advice.
Updated
What happened recently for Twist Bioscience Corp (TWST) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$118.57
Market cap
$7.44B
Profitable
No
Net income
$-77.67M
FY Sep 30, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Twist Bioscience Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Twist Bioscience Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.